APA (7th ed.) Citation

Tomar, T., de Jong, S., Alkema, N. G., Hoekman, R. L., Jan Meersma, G., Kilp, H. G., . . . Wisman, G. B. A. (2016). Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways. Genome Medicine, 8, 1. https://doi.org/10.1186/s13073-016-0361-5

Chicago Style (17th ed.) Citation

Tomar, Tushar, Steven de Jong, Nicolette G. Alkema, Rieks L. Hoekman, Gert Jan Meersma, Harry G. Kilp, Ate GJ van der Zee, and G. Bea A. Wisman. "Genome-wide Methylation Profiling of Ovarian Cancer Patient-derived Xenografts Treated with the Demethylating Agent Decitabine Identifies Novel Epigenetically Regulated Genes and Pathways." Genome Medicine 8 (2016): 1. https://doi.org/10.1186/s13073-016-0361-5.

MLA (9th ed.) Citation

Tomar, Tushar, et al. "Genome-wide Methylation Profiling of Ovarian Cancer Patient-derived Xenografts Treated with the Demethylating Agent Decitabine Identifies Novel Epigenetically Regulated Genes and Pathways." Genome Medicine, vol. 8, 2016, p. 1, https://doi.org/10.1186/s13073-016-0361-5.